Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Science
Pipeline
About Us
News & Media
Resources
Investors
Contact Us

Corporate Presentation – Harnessing the Power of Sulforaphane

steve | 4 January 2022

Categories:

Post navigation

← Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma, Pharmaceuticals, 26 October 2021

Notice of AGM →

Copyright© 2023 ICO Reg: ZB396415

Website Privacy Policy and Cookie Policy
Sitemap